PURPOSE Machine Learning Package for Cancer Diagnosis (MLCD) is the result of a National Institutes of Health/ National Cancer Institute (NIH/NCI)-sponsored project for developing a unified software package from state-ofthe-art breast cancer biopsy diagnosis and machine learning algorithms that can improve the quality of both clinical practice and ongoing research.
INTRODUCTION
The long-term goal of the National Institutes of Health/ National Institute of Cancer (NIH/NIC)-sponsored project, "A Unified Machine Learning Package for Cancer Diagnosis" (U01CA231782), which is part of the Information Technology for Cancer Research (ITCR) program, was the development of a unified software package for the diagnosis of cancer from whole-slide biopsy images. This article describes the resulting software, which leverages machine learning to automatically identify biomarkers, including a range of pathologic tissue types and possible cancer diagnostic categories, and can aid in improving the quality of both cancer research and clinical practice.
The field of pathology has been slow to move in an increasingly digitized age. However, US Food and Drug Administration authorization in April 2017 allowed the marketing of the first whole-slide imaging system for interpreting digital pathology slides from biopsy tissue samples, 1 expanding our potential for research and opening opportunities in clinical practice for using digitized images in diagnostic assessment. NIH/NCIsponsored research grants, including our own (R01 CA140560; R01 CA172343) have produced uniquely well-characterized biopsy images and methodology for finding regions of interest (ROIs), 2 segmenting them into histopathologic tissue types, 3 and using this segmentation as input to classifiers that suggest diagnoses. 4 These methods are being converted into a unified Python software package, Machine Learning Package for Cancer Diagnosis (MLCD), with the corresponding modules available through the GitHub repository under the Massachusetts Institute of Technology license, to be distributed later with the Pathology Image Informatics Platform (PIIP) system developed by Martel et al. 5 A demonstration is available on our Web page: https:// cancertech.cs.washington.edu. This article describes a software system suitable for a range of specialists, including cancer researchers Author affiliations and support information (if applicable) appear at the end of this article.
Accepted on February 5, 2020 and published at ascopubs.org/journal/ cci on March 27, 2020: DOI https://doi. org/10.1200/CCI. 19 . 00129 studying large image data sets, practicing pathologists, experts who want a second opinion, and pathology residents who are learning the diagnostic process. There are many existing platforms, including those being developed in the ITCR program, that contain useful tools, but whose scopes differ from ours. HistomicsTK, developed by Cooper and Gutman et al, 6 produces an image management platform and a set of generic image analysis algorithms for use in cancer biopsy image analysis. However, their breast cancer diagnostic tools lack the ROIs, segmentation, and diagnosis features offered in our software. Similarly, the XNAT platform, developed by Marcus et al, 7 includes operational tools for data importing, exporting, archiving, organizing, sharing, visualizing, and reporting. The QuIP system, developed by Saltz et al, 8 provides Web applications and analysis algorithms to load whole-slide images, detect nuclei in image tiles, and both visualize and explore the results. Saltz et al 9 also has developed convolutional neural network (CNN) models for detecting patches containing lymphocytes and necrosis, which is related to our semantic segmentation module. QuIP differs in emphasis from our MLCD system, which is oriented toward fully automated whole-slide diagnosis. Our ROI detection is based on interest by examining pathologists, whereas theirs is based on tissue classification.
Our ROI tools are designed to help pathologists with their initial scanning of digital slides; these tools will be useful in studying the way pathologists identify diagnostic ROIs. Our tissue segmentation tools are designed to help cancer researchers study tissue type classification. Our diagnostic tools are designed to perform computer-aided diagnoses; researchers can use them to improve the quality of their studies, and in the future, practitioners can use them in their clinical work. For cancer researchers, most of our tools are generalizable from our breast cancer studies to other cancer types through retraining on new data sets. Thus, our tools will have a significant impact on both cancer research and clinical practice.
METHODS

Overview
Our package is based on algorithms from the research articles mentioned in the Introduction and has 3 main modules as shown in Figure 1 , Region-of-Interest Detection, Tissue Segmentation, and Diagnosis Classifiers. The workflow begins with digital whole-slide hematoxylin and eosin-stained (H&E) images whose average size is 90,000 × 70,000 pixels. The Region-of-Interest Detection module is a classifier that, based on training data from pathologists, selects regions within whole-slide images that are most likely to be useful in diagnosis and provides them to the user. The user can select one and send it to the next module, the Tissue Segmentation module, which uses a CNN that was trained on 58 ROI images whose pixels were manually labeled by an experienced pathologist with their tissue classes: background, benign epithelium, malignant epithelium, normal stroma, desmoplastic stroma, secretion, blood, and necrosis. The resultant segmentation, in the form of a labeled image, is for use in the third module: the Diagnosis Classifier. The Diagnosis Classifier is a set of support vector machines (SVMs) that takes feature vectors extracted from the labeled image and produces 1 of 4 different diagnoses: benign, atypia, ductal carcinoma in situ (DCIS), and invasive cancer. These classifiers were trained on data from our research projects. We will, in future work, also provide untrained classifiers for each step that can be trained by other researchers on their data.
ROI Detection
Diagnostically relevant ROIs are represented using a visual bag-of-words model. 10 This module computes a dictionary from small image patch clusters, which are its "words." Then, the frequency of these words is used to describe larger image regions. Using frequency features, a classifier is trained to detect ROIs. The method consists of 2 major parts: (1) an ROIFeatureExtractor module, and (2) an ROIWindowClassifier module, both derived from algorithms developed by Mercan et al. 2 
CONTEXT
Key Objective
Our goal was to create a software package that can automatically find, segment, and diagnose regions of interest in whole-slide biopsy images. Knowledge Generated A software package has been developed that uses classifiers to predict regions of interest to semantically segment them using a deep neural net and to classify them using a support vector machine into clinically relevant diagnostic categories. Relevance Our tools have the potential to help other cancer researchers and, with appropriate interfaces, support software-assisted interpretation of cancer biopsy slides by clinicians.
The ROIFeatureExtractor takes in a whole-slide image and produces a feature vector that is used by the ROI-WindowClassifier module. The input whole-slide image needs to be in a supported format, including TIFF, JPEG, BMP, or PNG. 1 Other unsupported formats must first be converted. To achieve the optimal result, resolution of ×40 is recommended. Other resolutions are valid input, but the result might not be accurate because downsampling can cause information loss. The feature extractor consists of several internal submodules. First, a word constructor separates images into square patches called "words," whose sizes are 120 × 120 pixels. Next, these visual words are converted from the RGB (red-green-blue) color space to the H&E space, using color deconvolution and stain normalization algorithms developed by Macenko et al. 11 The visual words are also converted from the RGB color space into the L*a*b* color space using a nonlinear transformation. 12 The L*a*b color space consists of 3 axes: R-G (red-green), Y-B (yellow-blue), and gray tone, and was the result of perceptual studies with humans conducted by He and Wang. 13 Two histograms are then computed to describe the visual words: (1) a color histogram in the L*a*b* color space and (2) 
Tissue Segmentation
Tissue segmentation has 2 parts: (1) a CNN is trained from expert ground truth data to classify tissues at the pixel level into histopathologic classes, and (2) images are broken into superpixels, which are small, compact areas of the image that have similar color and texture; then, each superpixel is assigned the class label of the majority of its pixels (Fig 2) . The superpixel labels, which are the 8 identifiable tissue classes given in the Overview, will be used by the diagnostic classifiers. Figure 2 shows these classes in our ground truth ROI images.
The module SuperpixelSegmentation segments images into nonoverlapping superpixels, using a standard simple linear iterative clustering algorithm, which clusters neighboring pixels based on L, a, b values of the CIELAB color space. 3 Superpixel segmentation is a traditional unsupervised feature-based segmentation method originally developed by Ren and Malik. 15 CNNs are powerful tools for supervised semantic segmentation. [16] [17] [18] To better fit the whole-slide image problem, we developed a U-Net style encoder-decoder architecture 19 that uses modules from the ESPNet architecture developed by Mehta et al 20, 21 for better encoding spatial representations and with several modifications to conventional models: (1) an input-aware encoding block, (2) a new dense connection pattern between encoder and decoder, and (3) a combination of contextual features from multiple decoding paths. 3, 20, 21 In the PixelClassification module, semantic segmentation of biologically meaningful tissues is performed as a multiclass classification of individual pixels using the modified ESPNetbased encoder-decoder model. Our CNN model was trained on size 384 × 384 patches from 58 ROIs fully annotated by an experienced pathologist. Applying this trained CNN classifier on any given ROI yields a labeled image where the tissue types are represented by different integer labels and can be visualized in different colors: 0, Background (white); 2, Benign Epithelium (magenta); 3, Malignant Epithelium (blue); 4, Normal Stroma (pink); 5, Desmoplastic Stroma (violet); 6, Secretion (green); 7, Blood (yellow); 8, Necrosis (red). The next module, SuperpixelClassification, classifies each superpixel with the class of the majority of its pixels. Figure 3 shows an example of labeled superpixels surrounding a duct.
Diagnosis
Starting with a labeled ROI image, our diagnostic classifiers use the extracted tissue or structure features to produce 1 of 4 diagnoses from benign, atypia, DCIS, and invasive cancer. The modules included in the diagnosis package are as follows: (1) ROIs. These modules come from the algorithms developed by Mercan et al. 4 The SuperpixelFrequency module takes in a labeled ROI as shown in Figure 3 and produces an 8-bin histogram of the frequencies of each of the 8 histopathologic tissue labels in the ROI. The SuperpixelCo-occurrence module produces an 8-× 8-bin histogram, in which the (i, j) th bin contains the frequency of label i appearing adjacent to label j in the ROI. Superpixel co-occurrence can show the frequency of contact between superpixels of different tissue types. Figure 4 shows an example of a segmented tissue map and its superpixel label frequency histogram and superpixel label co-occurrence histogram.
The MidLevelFeatureClassifier module is a 4-class classifier trained from the feature vectors computed by the Super-pixelFrequency and SuperPixelCo-occurrence modules on 428 ROIs in the full data set. Given the frequency and cooccurrence histograms of segmented ROIs, the classifier assigns 1 of the 4 diagnosis labels: benign, atypia, DCIS, and invasive.
The StructureFeature module was developed with the advice of expert pathologists to describe the structures they pay close attention to during diagnosis, in particular, structural changes surrounding a duct. Using the semantic segmentation result, objects of interests or central structures (ducts) are identified, and the feature extraction process is applied: 1 superpixel-wide layers of superpixels toward the inside of the object and toward the outside. For each layer, a frequency histogram of tissue labels of superpixels within each such layer is constructed. 
RESULTS
This software package comes from research work whose code was written in multiple languages and packages, including C++, MATLAB, and Torch. All of the software is being converted to Python modules to produce a uniform machine-learning-based package. The modules described in this article are complete, with the exception of the ongoing work on the StructureFeature extractor and classifier; they can be downloaded from https://github.com/cancertech/ cancer_diagnosis. Instructions for using the package are given on our Web page (https://cancertech.cs.washington. edu/), which has tabs for downloading the whole package as a zip file, installation of required software including Anaconda/Python, and a tutorial that takes the user through the process of running the package on an image through the whole pipeline. Figure 6 shows sample results, which are more comprehensive than the simple example in the tutorial. 
DISCUSSION
Our scientific methodology was produced by a multidisciplinary team consisting of world experts in epidemiology, breast pathology, and computer vision/machine learning. The current classifiers are all trained on a specific and welldeveloped breast biopsy data set. Although they are meant to be used on breast cancer whole-slide images, we plan to make the untrained versions of the classifiers available for researchers to use on their own data sets, with an extension to other cancers in the near future. The methodology has been shown to be transferable to our current work on a melanoma biopsy set. Pathologists' annotations and tracking data can be used to train a (new) ROI classifier. An expert pathologist can mark the borders of different tissues on ROIs (ongoing), and then the Tissue Segmentation module can work in the same way. The labels, of course, are different for different tissue types. Once the semantic segmentation is completed, the diagnostic classification through label frequency and co-occurrence can run as described. However, the structure feature was meant for ducts or other small areas, such as glands, that would not apply to all cancers.
The package was initially intended for cancer researchers but shows functionality for practitioners. In both cases, a suitable interface to improve the user experience will be necessary. In its current state, the software must be downloaded from GitHub, and the modules are run by the user because some of them extract features from large images. The long-term plan is to make the software available through the PIIP package. 5 PIIP is an NCI/NIHsponsored project intended for managing, annotating, sharing, and quantitatively analyzing digital pathology imaging data that expands on an existing, freely available pathology image viewer, Sedeen. We chose the PIIP/ Sedeen platform because it is readily available, is easy to use, and provides excellent annotation tools for training deep-learning classifiers, Sedeen will read in a whole-slide image and pass it to the tools of our package, which will reside in PIIP. Because Sedeen is Windows based, our first software is also Windows based, but we will provide Linux and MacOS as well in the near future. SVS format will be supported on Linux and MacOS after installation of openslide (see https://openslide.org/download/ for installation details).
Software development for computer-aided cancer diagnosis is one of the most difficult problems in cancer informatics
Ground truth ROIs research and requires a dynamic and strategic research team for our NIH/NCI-sponsored project, U01 CA231782. The resulting design for AI-assisted diagnosis includes ROI finding, tissue segmentation into histopathologic classes using a state-of-the-art deep-learning scheme and classification into multiple diagnosis categories using hand-crafted features and SVMss. Our new tools show applicability and adaptability to a range of cancer researchers beyond our initial research into breast cancer data sets and eventually to practicing pathologists, from residents who are learning diagnostic skills to experts who want a quick second opinion on patients for which additional advice is desired.
